Wednesday, June 9, 2010

Brain Cancer Treatment Latest Discovery

NovoTTF is the name of the newly discovered device in Chicago that is said to be helpful in treating brain cancer. This is an easy to carry non-invasive device that will be using electrical field in order to destroy cancer cells. NovoTTF or novo Tumor Treating Fields was made by a private company which is the NovoCure Ltd. The goal of the device is primarily for patients with glioblastoma which is consider as the most common form of brain cancer. It is said that this has been introduced to some country and was approved in Europe.
Brain CancerGlioblastomas are indeed very difficult to treat and percentage of mortality rate is high. This was first introduced at the American Society of Clinical Oncology and they confirmed that the cure rate of the device is not yet known. Though lots of the cancer doctors are very much interested with the new discovery the truth is that it is not yet well proven.
NovoTTF works by using electrical fields which used insulated electrodes and then this will be applied in an indibidual with the use of large white bandage in the scalp. It is said that the device are not harmful to the healthy cells in the brain. A little side effect of this device is that is cause scalp irritation. This can work with the use of battery pack and can this is very small that can be brought easily.
The study shows that the patients who used NovoTTF is significantly had less side effects compare to those people who rather chose the chemotherapy treatment. The NovoCure Company is now planning to contact the U.S. Food and Drug Administration in order to share the study results and apply for its approval. There is little evidence about how the device can work and contribute with the improvement of brain cancerpatients. Some scientists said that the device is only use to slowdown the development of brain cancer treatment and not completely cure the patient.
The study for NovoTTF is still on going and they are planning to get the 283 brain cancer patients from U.S and Europe.

No comments:

Post a Comment